Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephen Lok"'
Autor:
Dana Gebhart, Stephen Lok, Simon Clare, Myreen Tomas, Mark Stares, Dean Scholl, Curtis J. Donskey, Trevor D. Lawley, Gregory R. Govoni
Publikováno v:
mBio, Vol 6, Iss 2 (2015)
ABSTRACT Clostridium difficile is a leading cause of nosocomial infections worldwide and has become an urgent public health threat requiring immediate attention. Epidemic lineages of the BI/NAP1/027 strain type have emerged and spread through health
Externí odkaz:
https://doaj.org/article/56d6053b8e4743aea292009135fb17f2
Autor:
Kyle Landgraf, Kole T. Roybal, Stephen Lok, Steven R. Williams, Dana Gebhart, Daniel P. Steiger, Kaman Chan Kim, David W. Martin
Publikováno v:
Communications biology, vol 3, iss 1
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
Communications Biology
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
Communications Biology
We have developed a chimeric antigen receptor (CAR) platform that functions as a modular system to address limitations of traditional CAR therapies. An inert form of the human NKG2D extracellular domain (iNKG2D) was engineered as the ectodomain of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a90dbc04ac2d6051c2921a23a2a7945
https://escholarship.org/uc/item/2cd0685z
https://escholarship.org/uc/item/2cd0685z
Autor:
Dean Scholl, Anthony M. Buckley, Dana Gebhart, Gregory R. Govoni, Gillian Douce, Stephen Lok, Joseph A. Kirk, Robert P. Fagan
Publikováno v:
Science Translational Medicine. 9
There is a medical need for antibacterial agents that do not damage the resident gut microbiota or promote the spread of antibiotic resistance. We recently described a prototypic precision bactericidal agent, Av-CD291.2, which selectively kills speci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::376a43de94f787f896ba3c1789fccea3
https://doi.org/10.1126/scitranslmed.aah6813
https://doi.org/10.1126/scitranslmed.aah6813
Autor:
Joseph A, Kirk, Dana, Gebhart, Anthony M, Buckley, Stephen, Lok, Dean, Scholl, Gillian R, Douce, Gregory R, Govoni, Robert P, Fagan
Publikováno v:
Science translational medicine. 9(406)
Avidocin-CDs are a new class of precision bactericidal agents that do not damage resident gut microbiota and are unlikely to promote the spread of antibiotic resistance. The precision killing properties result from the fusion of bacteriophage recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::904f51b8ee0854eb5b666d943119f492
https://pubmed.ncbi.nlm.nih.gov/28878013
https://pubmed.ncbi.nlm.nih.gov/28878013
Autor:
Stephen Lok, Scott A. Richardson
Publikováno v:
Review of Accounting Studies. 16:487-500
The last decade has seen rapid growth in trading of credit instruments on secondary markets. The ensuing availability of a rich set of credit market data has created a novel environment for testing a variety of financial economic theories. In this di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ec66f9b47906a8b7202a7b9902e4fb
https://doi.org/10.1007/s11142-011-9147-6
https://doi.org/10.1007/s11142-011-9147-6
Autor:
Trevor D. Lawley, Simon Clare, Gregory R. Govoni, Dean Scholl, Stephen Lok, Myreen Tomas, Curtis J. Donskey, Dana Gebhart, Mark D. Stares
Publikováno v:
mBio, Vol 6, Iss 2 (2015)
Clostridium difficile is a leading cause of nosocomial infections worldwide and has become an urgent public health threat requiring immediate attention. Epidemic lineages of the BI/NAP1/027 strain type have emerged and spread through health care syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f7e437972d81a8c2205cebfcba83a1
https://pubmed.ncbi.nlm.nih.gov/25895936
https://pubmed.ncbi.nlm.nih.gov/25895936